JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
Efficiency and safety of N-butyl cyanoacrylate versus coils in acute bleeding embolization
Aims: This study aimed to evaluate and compare the technical success, clinical efficacy, and safety of N-butyl cyanoacrylate (NBCA) versus coil embolization in the endovascular management of acute hemorrhage.
Methods: Between July 2024 and November 2025, 33 patients who underwent embolization for acute bleeding, including abdominal wall, gastrointestinal, renal, soft tissue, and tumoral hemorrhages, were retrospectively analyzed. The study population consisted of the NBCA group (n=16) and the coil group (n=17). Technical success was defined as the complete angiographic occlusion of the target vessel and cessation of contrast extravasation. Clinical success was defined as symptomatic improvement during hospitalization without the need for re-intervention, recurrent bleeding, or mortality. Procedural times, success rates, and complication rates were compared between the two groups.
Results: Technical success was achieved in 100% of cases in both groups. Clinical success rates were 87.5% (14/16) in the NBCA group and 76.5% (13/17) in the coil group. Embolization time was significantly shorter in the NBCA group (10.6±3.4 min) than in the coil group (22.0±15.4 min) (p=0.0079). Re-bleeding rates were 12.5% for the NBCA group and 23.5% for the coil group, showing no significant difference (p=0.407). No major complications or non-target embolization events occurred in either group.
Conclusion: No statistically significant differences were observed in clinical success, re-bleeding, or complication rates between the NBCA and coil groups in our cohort. However, the use of NBCA was associated with significantly shorter embolization times, which may offer a potential advantage in the management of acute arterial bleeding.


1. Ierardi AM, Piacentino F, Pesapane F, et al. Basic embolization techniques: tips and tricks. Acta Biomed. 2020;91(Suppl 8):71-80. doi:10. 23750/abm.v91i8-S.9974
2. Tsetis D, Uberoi R, Fanelli F, et al. The provision of interventional radiology services in Europe: CIRSE recommendations. Cardiovasc Intervent Radiol. 2016;39(4):500-506. doi:10.1007/s00270-016-1299-0
3. Wang CY, Hu J, Sheth RA, Oklu R. Emerging embolic agents in endovascular embolization: an overview. Prog Biomed Eng (Bristol). 2020;2(1):012003. doi:10.1088/2516-1091/ab6c7d
4. Grange R, Habouzit V, Lanoiselee J, et al. Clinical success and safety of N-butyl cyanoacrylate in emergency embolization: is operator experience a key factor? Quant Imaging Med Surg. 2025;15(3):1963-1976. doi:10.21037/qims-24-1767
5. Gong M, He X, Zhao B, Kong J, Gu J, Su H. Transcatheter arterial embolization with N-Butyl-2 cyanoacrylate glubran 2 for the treatment of acute renal hemorrhage under coagulopathic conditions. Ann Vasc Surg. 2022;86:358-365. doi:10.1016/j.avsg.2022.04.010
6. Arik E, Soydemir E, Yer B, et al. Management of spontaneous abdominal wall hematomas: a narrative review with a focus on CTA-negative endovascular cases. CVIR Endovasc. 2026;9:4. doi:10.1186/s42155-025-00647-7
7. Filippiadis D, Pereira PL, Hausegger KA, Ryan AG, Binkert CA. CIRSE standards of practice for the classification of complications: the modified CIRSE classification system. Cardiovasc Intervent Radiol. 2025. doi:10.1007/s00270-025-04200-w
8. Hörer TM, Ierardi AM, Carriero S, Lanza C, Carrafiello G, McGreevy DT. Emergent vessel embolization for major traumatic and non-traumatic hemorrhage: indications, tools and outcomes. Semin Vasc Surg. 2023;36(2):283-299. doi:10.1053/j.semvascsurg.2023.04.011
9. Grange R, Grange L, Chevalier C, et al. Transarterial embolization for spontaneous soft-tissue hematomas: predictive factors for early death. J Pers Med. 2022;13(1):15. doi:10.3390/jpm13010015
10. Chevallier O, Comby PO, Guillen K, et al. Efficacy, safety and outcomes of transcatheter arterial embolization with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding: a systematic review and meta-analysis. Diagn Interv Imaging. 2021;102(7-8):479-487. doi:10.1016/j.diii. 2021.03.004
11. Hur S, Jae HJ, Lee M, Kim HC, Chung JW. Safety and efficacy of transcatheter arterial embolization for lower gastrointestinal bleeding: a single-center experience with 112 patients. J Vasc Interv Radiol. 2014; 25(1):10-19. doi:10.1016/j.jvir.2013.09.012
12. Loffroy R, Desmyttere AS, Mouillot T, et al. Ten-year experience with arterial embolization for peptic ulcer bleeding: N-butyl cyanoacrylate glue versus other embolic agents. Eur Radiol. 2021;31(5):3015-3026. doi: 10.1007/s00330-020-07427-y
13. Abdulmalak G, Chevallier O, Falvo N, et al. Safety and efficacy of transcatheter embolization with Glubran®2 cyanoacrylate glue for acute arterial bleeding: a single-center experience with 104 patients. Abdom Radiol. 2018;43(3):723-733. doi:10.1007/s00261-017-1267-4
14. Narkhede A, Yadav AK, Gupta A. N-Butyl cyanoacrylate embolization in management of iatrogenic renal hemorrhages-single-center study evaluating safety and efficacy. J Clin Int Radiol ISVIR. 2021;06:75-82. doi:10.1055/s-0041-1732795
15. Arik E, Taydas O, Ozer I, et al. Efficacy and safety of endovascular treatment for iatrogenic renal injuries following percutaneous interventions. Videosurg Other Miniinvas Techniq. 2025;20(4):464-470. doi:10.20452/wiitm.2025.17996
Volume 9, Issue 3, 2026
Page : 754-760
_Footer